Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD133 (clone AC1G33). We employs the AAV (CMV-Cy2-c-Jun-HindIII) vector components and the SynExpress system of the lncRNA Base Editing/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD133
Clone
AC1G33
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy2
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
AAV
Transformation Accuracy
0.87
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.